Stocklytics Platform

Income Statement

publish
The Stocklytics Income Statement Screener empowers investors to focus on companies with strong financial fundamentals. Whether you’re interested in growth, profitability, or overall revenue strength, this tool helps you make informed decisions.
name
arrow_downwardRevenue Price $ Change % Change Revenue Growth % Gross Profit Operating Income Net Income EBITDA EPS Diluted
Asset logo for symbol OXBR
OXBROxbridge Re Holdings Ltd
_$1.80$0.06arrow_drop_up3.73%-_-$9.23M-$9.91M-$3.98M-0.83
Asset logo for symbol NBY
NBYNovaBay Pharmaceuticals
_$0.56$0.00arrow_drop_up0.52%arrow_drop_up2.23%$7.89M-$5.00M-$9.64M-$5.39M-74.61
Asset logo for symbol NUE
NUENucor
_$108.18-$0.59arrow_drop_down0.53%-$4.10B$2.97B$2.31B$4.60B8.45
Asset logo for symbol EYEN
EYENEyenovia
_$1.73-$0.23arrow_drop_down11.33%-_-$25.40M-$27.26M-$35.64M-55.20
Asset logo for symbol AGRI
AGRIAgriFORCE Growing Systems, Ltd.
_$1.52-$0.04arrow_drop_down2.61%-$2,704.00-$11.15M-$11.73M-$4.93M-1.78
Asset logo for symbol INNV
INNVInnovus Pharmaceuticals
_$3.92-$0.10arrow_drop_down2.48%arrow_drop_up11.01%$132.06M-$23.18M-$23.22M$1.15M-0.19
Asset logo for symbol VERO
VEROVenus Concept
_$2.24$0.02arrow_drop_up1.12%-$52.16M-$28.30M-$37.05M-$24.15M-7.97
Asset logo for symbol USNA
USNAUSANA Health Sciences
_$29.35-$0.70arrow_drop_down2.32%-$744.31M$93.07M$63.78M$114.04M2.19
Asset logo for symbol WINT
WINTWindtree Therapeutics
_$0.76$0.02arrow_drop_up3.19%-_-$17.53M-$20.29M-$24.68M-19.03
Asset logo for symbol ISPC
ISPCiSpecimen
_$1.09-$0.04arrow_drop_down3.94%-$5.10M-$11.16M-$11.09M-$9.50M-18.12
Asset logo for symbol MINM
MINMMinim
_$1.76-$0.09arrow_drop_down4.86%-$470.88K-$17.20M-$17.63M-$2.81M-5.29
Asset logo for symbol VCNX
VCNXVaccinex
_$1.41-$2.27arrow_drop_down62.19%-$570.00K-$22.88M-$20.25M-$20.23M7.42
Asset logo for symbol OMI
OMIOwens & Minor
_$6.45-$0.41arrow_drop_down6.03%arrow_drop_up3.55%$20.74K-$1,940.00-$362.68M$556.14M-4.73
Asset logo for symbol MCS
MCSMarcus
_$17.06$0.14arrow_drop_up0.85%arrow_drop_up0.82%$669.17M$16.17M-$7.78M$88.83M-0.25
Asset logo for symbol RSLS
RSLSReShape Lifesciences
_$4.83-$0.11arrow_drop_down2.22%-$5.54M-$14.63M-$11.38M-$7.89M76.20
BENF
BENFBeneficient
_$0.33-$0.00arrow_drop_down2.85%-_-$2.74B-$2.09B-$87.81M-220.95
Asset logo for symbol XELAP
XELAPExela Technologies, Inc. - 6.00% Series B Cumulative Convertible Perpetual Preferred Stock
_$1.09-$0.14arrow_drop_down11.38%-$232.64M$8.05M-$125.15M$59.86M-0.85
Asset logo for symbol KODK
KODKEastman Kodak Co
_$5.89-$0.06arrow_drop_down1.00%-$210.00M$4.00M$75.00M$199.00M0.70
Asset logo for symbol TANH
TANHTantech Holdings Ltd
_$2.12-$0.03arrow_drop_down1.62%-$10.17M$1.83M$5.58M$4.86M46.80
Asset logo for symbol SHPH
SHPHShuttle Pharmaceuticals Holdings
_$0.17-$0.00arrow_drop_down5.19%-_-$7.69B-$9.14B-$7.19M-3.30
Showing 3561-3580 of 4978
Results per page:

Gain deeper insights into a company's earnings with the Stocklytics Income Statement Screener, designed to rank stocks in descending order of revenue. This tool allows you to quickly assess companies with the highest revenue and their overall income performance, providing key financial metrics for smarter investment decisions. Our screener offers detailed insights into the following income statement components: - Revenue Growth – Identify companies with impressive year-over-year growth, a critical indicator of potential future success. - Gross Profit – Analyze how well a company is managing its core production costs to generate profit. - Operating Income – Understand a company’s ability to generate profit from its primary operations, excluding non-operational activities. - Net Income – Examine the company's bottom line after all expenses, providing a clear picture of profitability. - EBITDA – Evaluate a company’s earnings before interest, taxes, depreciation, and amortization to get a sense of its overall profitability and operating performance. - EPS Diluted – Review earnings per share on a diluted basis, reflecting potential impacts of convertible securities and giving you a clearer picture of shareholder returns. By using the Stocklytics Income Statement Screener, you’ll have access to vital financial data that will help you evaluate a company's performance, profitability, and growth potential. Why the Income Statement Matters: - Revenue Performance: Understand which companies are excelling at generating top-line revenue. - Profitability: Analyze margins and earnings to identify financially strong companies. - Earnings Per Share: Evaluate companies with high earnings per share, a key metric for investors.
toolkit image

Discover the Power of Stocklytics Tools

Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.

See Stocklytics Tools

Take Your Investments to a Whole New Level